6
Shared Docs
6
Same-Page
6 / 6
Mentions
tes: <7.0 Prostate-Specific Ag, Serum Prostate Specific Ag, Serum Roche ECLIA methodology. 0.8 ng/mL 4.8 - 5.6 02 0.0 - 4.0 02 According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA
ency as a level between 21 and 29 ng/mL (2). 1. ION (Institute of Medicine). 2010. Dietary reference intakes for calcium and D. Washington DC: The National Academies Press. 2. Bolick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinica
3092 UulowbenKkb/403-2377 4 DatitcoftalictO9/114M81/nLMM TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB Roche ECLIA methodology. According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA
ncy as a level between 21 and 29 ng/aL (2) • 1. IOM (Institute of Medicine). 2010. Dietary reference intakes for calcium and D. Washington DC: The National Academies Press. 2. Bolick mr, Hinkley MC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinica
ults with diabetes: <7.0 Prostate-Specific Ag, Serum Prostate Specific Ag, Serum 0.7 ng/mL 0.0 - 4.0 01 Roche ECLIA methodology. According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA
ency as a level between 21 and 29 ng/mL (2). 1. ZOE (Institute of Medicine). 2010. Dietary reference intakes for calcium and D. Washington DC: The National Academies Press. 2. Bolick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinica
ITS REFERENCE INTERVAL LAB Prostate-Specific Ag, Serum Prostate Specific Ag, Serum Roche ECLIA methodology. 0.6 ng/mL 0.0 - 4.0 According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA
ency as a level between 21 and 29 ng/mL (2). 1. IOM (Institute of Medicine). 2010. Dietary reference intakes for calcium and D. Washington DC: The National Academies Press. 2. Holick MF, Hinkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine society clinica
257-S80-2371D Date collected:09/14/2018 1255 Local TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB TSH Roche ECLIA methodology. According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA
ency as a level between 21 and 29 ng/mL (2). 1. IOM (Institute of Medicine). 2010. Dietary reference intakes for calcium and D. Washington DC: The National Academies Press. 2. Bolick MP, Hinkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinica
with diabetes: <7.0 01 Prostate-Specific Ag, Serum Prostate Specific Ag, Serum 0.7 ng/mL 0.0 - 4.0 01 Roche ECLIA methodology. According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA
ency as a level between 21 and 29 ng/mL (2). 1. IOM (Institute of Medicine). 2010. Dietary reference intakes for calcium and D. Washington DC: The National Academies Press. 2. Holick MP, Hinkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinica
Entities connected to both the American Urological Association and National Academies Press
Bischoff-Ferrari HA
ORGANIZATIONThe Endocrine Society
ORGANIZATION
Jeffrey Epstein
PERSONRaritan
LOCATIONBurlington
LOCATIONCardiac
ORGANIZATION
NEW YORK NY
LOCATIONC-Reactive Protein
ORGANIZATIONWilliam F Hancock
PERSONHinkley NC
LOCATIONProstate-Specific Ag
ORGANIZATIONIron Bind
ORGANIZATIONBEI - Inorganic Mercury
ORGANIZATIONLabCorp Burlington
ORGANIZATIONMetabolic Panel
ORGANIZATIONNon Reactive
ORGANIZATIONIGF-1
ORGANIZATIONNon-Parathyroid Hypocalcemia
ORGANIZATIONLipid Panel
ORGANIZATIONAlkaline Phosphatase
PERSON